What is the clinical evidence from this study?

Study design: Cohort. Population: Acute myocardial infarction with high intracoronary thrombus burden (n=60). Intervention: AngioJet rheolytic thrombectomy during PTCA vs. Standard PTCA procedure. Primary outcome: Major adverse cardiac events (MACE) (p=0.026).

What question did this study set out to answer?

To compare the immediate angiographic and 1-year clinical outcomes of AngioJet rheolytic thrombectomy combined with percutaneous transluminal coronary angioplasty (PTCA) against standard PTCA alone in acute myocardial infarction patients with high thrombus burden.

July 19, 2007Journal of Interventional Cardiology

Rheolytic Thrombectomy during Percutaneous Coronary Intervention Improves Long‐Term Outcome in High‐Risk Patients with Acute Myocardial Infarction

View Full Paper

Ask AI

Bookmark

Key result

AngioJet rheolytic thrombectomy during PTCA in high-risk AMI patients significantly reduced 1-year MACE (10% vs 30%, P=0.026) and death (3.33% vs 13.33%, P<0.001) compared to standard PTCA.

Why the study?

Does AngioJet rheolytic thrombectomy during PTCA improve immediate angiographic and 1-year clinical outcomes in patients with AMI and high intracoronary thrombus burden compared to standard PTCA?

Key Points

To compare the immediate angiographic and 1-year clinical outcomes of AngioJet rheolytic thrombectomy combined with percutaneous transluminal coronary angioplasty (PTCA) against standard PTCA alone in acute myocardial infarction patients with high thrombus burden.
Evaluated 30 consecutive patients presenting with acute myocardial infarction and angiographic evidence of high thrombus burden who underwent AngioJet rheolytic thrombectomy followed by PTCA.
Compared outcomes against a control group of 30 consecutive patients with similar clinical presentation, risk profile, and high thrombus burden treated with standard PTCA alone, following patients for 1 year.
Patients treated with AngioJet achieved significantly higher rates of final TIMI 3 flow (93.3% vs 83.3%, P = 0.034) and a lower mean corrected TIMI frame count (22.4 vs 32.4, P = 0.0004) compared to standard PTCA.
At 1-year follow-up, the AngioJet group demonstrated significantly lower all-cause mortality (3.33% vs 13.33%, P < 0.001), major adverse cardiac events (10% vs 30%, P = 0.026), and repeat revascularization (6.67% vs 20%, P = 0.013).

Study Design

Type

Cohort (n=60)

Structured PICO

Does AngioJet rheolytic thrombectomy during PTCA improve immediate angiographic and 1-year clinical outcomes in patients with AMI and high intracoronary thrombus burden compared to standard PTCA?

Population

60 consecutive patients with acute myocardial infarction and angiographic evidence of high thrombus burden undergoing PTCA, followed for 1 year.

Exposure

AngioJet rheolytic thrombectomy performed during percutaneous coronary angioplasty (PTCA)

Comparator

Standard percutaneous coronary angioplasty (PTCA) procedure

Outcome

Immediate angiographic results (final TIMI flow grade 3, mean corrected TIMI frame count) and 1-year clinical outcomes (death, major adverse cardiac events [MACE], need of revascularization)hard clinical

Main Result

Absolute Event Rate: 10% vs 30%

p-value: p=0.026

Rheolytic thrombectomy during PTCA in AMI patients with high thrombus burden improves both immediate angiographic results and 1-year clinical outcomes, including mortality and MACE.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

May support rheolytic thrombectomy in high-thrombus AMI; leaves open need for randomized confirmation before practice change.

Cite This Study

Rosa et al. (2007) conducted a cohort in Acute myocardial infarction with high intracoronary thrombus burden (n=60). AngioJet rheolytic thrombectomy during PTCA vs. Standard PTCA procedure was evaluated on Major adverse cardiac events (MACE) (p=0.026). AngioJet rheolytic thrombectomy during PTCA in high-risk AMI patients significantly reduced 1-year MACE (10% vs 30%, P=0.026) and death (3.33% vs 13.33%, P<0.001) compared to standard PTCA.

synapsesocial.com/papers/6a9ba6c6d8d8bde79ebb05e0 https://doi.org/10.1111/j.1540-8183.2007.00271.x

View Full Paper

Ask AI

Bookmark

Rheolytic Thrombectomy during Percutaneous Coronary Intervention Improves Long‐Term Outcome in High‐Risk Patients with Acute Myocardial Infarction

Key Points

Study Design

Structured PICO

Main Result

Discussion

Implication

Cite This Study

Rheolytic Thrombectomy during Percutaneous Coronary Intervention Improves Long‐Term Outcome in High‐Risk Patients with Acute Myocardial Infarction

Key Points

Study Design

Structured PICO

Main Result

Discussion

Implication

Cite This Study

Also Consider

Also Consider